Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): Real-world evidence of NSCLC patients treated with radiochemotherapy in Germany – AIO-TRK-0315. 14. November 2022 Eberhardt WEE, Passlick B, Stuschke M, Groeschel A, Christopoulos P, Reck M, et al. 2022. Annals of Oncology. 2022 Sep;33(Supplement 7):S988. Download CRISP: First Real-World Evidence of NSCLC Stage I, II and III in Germany – AIO-TRK-0315 Stuschke M, Eberhardt WEE, Passlick B, Groeschel A, Christopoulos P, Reck M, et al. 2022. Abstract Book WCLC 2022, p. 579 EP05.01-030… Weiterlesen Klinische Plattform zur Erforschung molekularer Testung, Behandlung und Krankheitsverlauf von Patienten mit Lungenkrebs (CRISP): Real-World Evidence zu NSCLC Patienten behandelt mit Radiochemotherapie. Eberhardt WEE, Passlick B, Stuschke M, Groeschel A, Christopoulos P, Reck M, et al., 2022. Oncol Res Treat 2021;44:1–335… Weiterlesen